
- Telehealth Visits
- Insurance plan information

Erika Mae Reyes, OD
She | Her | HersOptometry- Telehealth Visits
- Insurance plan information



Erika Mae Reyes, OD
She | Her | HersOptometry- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Erika Mae Reyes is an optometrist who provides primary eye care to patients of all ages. Her expertise includes managing ocular conditions, such as dry eye, glaucoma, macular degeneration (damage to the part of the retina that controls central vision), cataracts and diabetic retinopathy (damage to retinal blood vessels caused by high blood sugar). She also prescribes glasses and contact lenses to address nearsightedness, farsightedness, astigmatism and other common vision problems.
In addition to providing comprehensive eye exams, Reyes performs eye exams for patients participating in clinical trials to evaluate promising new treatments for cancers, rheumatological diseases and other conditions.
Reyes earned her doctor of optometry degree from University of California, Berkeley School of Optometry, where she also completed a clinical research fellowship on dry eye disease and developing new contact lens materials and designs. Prior to joining UCSF, she worked in optometry and ophthalmology private practices in the Bay Area.
Reyes grew up in the Bay Area. She enjoys trying new restaurants and traveling.
Education & training
Fellowship
- Clinical Research, UC Berkeley School of Optometry
Degree
- OD, UC Berkeley School of Optometry
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%224137%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224137%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.